Aquablation is a robotic method that uses a high-pressure saline solution to remove tissue
News
EIP Pharma merges with CervoMed
The amalgamated company will focus on advancing neflamapimod for the treatment of dementia
NICE gives green light for MSD’s Keytruda
The decision is the first verdict based on data from a wider immunotherapy ‘basket’ study
Elfabrio receives vital MHRA authorisation
The therapy involves long-term enzyme replacement therapy for aduls with Fabry disease
NIH and Exothera in partnership to produce COVID-19 vaccine
The new vaccine is an alternative to injected versions and no medical training is needed to deliver it
Chiesi forms tech partnership with Aliada
The collaboration will focus on multiple enzyme cargoes modified using Aliada’s modular delivery platform
Calliditas reveals results from vital NefIgArd study
The study concerns the use of Nefecon among adult patients with primary IgA nephropathy
Evgen releases data from SFX-01 trial
The study is specifically analysing the company’s new enteric coated tablet formation of the drug
CymaBay begins phase 3 liver disease study
IDEAL study aims to determine the impact of seladelpar on alkaline phosphatase levels
CNX acquires four cancer drugs from Clinigen
The purchased therapies concerned are Cardioxane, Totect, Ethyol and Savene
Novartis’ remibrutinib shows promise for patients with CSU
Highly selective inhibitor therapy treats patients with chronic spontaneous urticaria
Atai Life delivers results from PCN-101 study
Data supports further exploration of candidate as a rapid-acting anti-depressant for home use
Green light for one of Europe’s largest life sciences campus
UBS Asset Management and Reef Group secure approval for the Stevenage-based facility
AlzeCure delivers positive NeuroRestore candidate results
The therapy reaches and activates areas of the brain that are central to cognitive enhancement
Astex reveals partnership with MSD
The partnership will establish small molecule candidates with a view to treating cancer
